Show simple item record

dc.contributor.authorLi, Shuhui
dc.contributor.authorFeng, Kairui
dc.contributor.authorLee, Jieon
dc.contributor.authorGong, Yuqing
dc.contributor.authorWu, Fang
dc.contributor.authorNewman, Bryan
dc.contributor.authorYoon, Miyoung
dc.contributor.authorFang, Lanyan
dc.contributor.authorZhao, Liang
dc.contributor.authorGobburu, Jogarao
dc.date.accessioned2022-03-15T13:04:49Z
dc.date.available2022-03-15T13:04:49Z
dc.date.issued2022-03-11
dc.identifier.urihttp://hdl.handle.net/10713/18263
dc.descriptionPresented at the Ph.D. Interview Day, March 11, 2022.en_US
dc.language.isoen_USen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshPharmacokineticsen_US
dc.subject.meshTherapeutic Equivalencyen_US
dc.subject.meshAdministration, Inhalationen_US
dc.subject.meshPowdersen_US
dc.titleEvaluating novel pilot pharmacokinetic bioequivalence study for inhalation powder drug products exhibiting batch-to-batch variabilityen_US
dc.typePoster/Presentationen_US
refterms.dateFOA2022-03-15T13:04:50Z


Files in this item

Thumbnail
Name:
SOP_Li_2022.pdf
Size:
949.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International